Skip to content
healthcare.dev

Zonisamide

NDC 68462-129, Zonisamide, capsule, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-129
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077651
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZONISAMIDE50 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
68462-129-0168462012901100 CAPSULE in 1 BOTTLE (68462-129-01)
68462-129-0568462012905500 CAPSULE in 1 BOTTLE (68462-129-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fe15e56e-8b86-4a65-825c-31d37dd81612
  • NADAC price for package 68462012901

    GET /v1/drugs/nadac/68462012901

Use it

Look up 68462-129 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-129. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.